FDA WARNING_LETTER - Wise Guys Vapes - February 09, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA issued a Warning Letter to Wise Guys Vapes on February 9, 2022, after reviewing submissions and inspection records. The FDA determined that Wise Guys Vapes manufactures and distributes e-liquid products, specifically "Wise Guys Whitey Bulger 3mg e-liquid," which are deemed tobacco products under the FD&C Act.
The primary violation is that this e-liquid product is a "new tobacco product" because it was not commercially marketed in the U.S. as of February 15, 2007, and lacks the required premarket authorization order under section 910(c)(1)(A)(i) of the FD&C Act. Consequently, the product is adulterated under section 902(6)(A) and misbranded under section 903(a)(6) of the FD&C Act due to the failure to provide required notice or information under section 905(j).
These actions constitute prohibited acts under sections 301(k) and 301(p) of the FD&C Act. The FDA emphasizes that all new tobacco products marketed without premarket authorization are unlawful and subject to enforcement, including civil money penalties, seizure, and injunction. Wise Guys Vapes must submit a written response within 15 working days detailing actions to address violations, including discontinuing sales/distribution and a plan for future compliance.
ID · 0f38dc12-e87a-42ea-b124-703bfe429326
Full citation text and observation details available on the Dashboard.